Modulight Oyj
Modulight is a Finnish biomedical technology company that designs and manufactures laser-based devices, software, cloud services, and specialized semiconductors. Its core business serves oncology, ophthalmology, genetics, and other high-value applications such as quantum technologies and digital printing, with operations centered in Tampere and sales to customers worldwide.
Fiscal year 2025 · change from previous year
Development 2022–2025
Business
Share of revenueLaser-based devices and treatment platforms used in oncology and eye care.
Application software, cloud connectivity, and SaaS tools that support device use.
Specialized semiconductor products used in Modulight systems and customer solutions.
Customer-specific systems, integration work, and project-based delivery.
Products for quantum technologies, flow cytometry, microscopy, and digital printing.
Customers
Modulight sells to pharmaceutical and biomedical companies, cancer centers, universities, and other life-science organizations that need laser-based treatment or research tools. It also serves customers in adjacent high-value technology fields, where customized photonics systems and specialized components are required. The business model depends on long development cycles, customer-specific solutions, and recurring use of software and cloud services alongside hardware.
Buy laser systems, software, and services for drug-linked treatment workflows and clinical programs.
Use treatment devices and application systems for oncology workflows and patient care.
Purchase systems for research, prototyping, and advanced biomedical applications.
Buy specialized photonics and semiconductor solutions for quantum, printing, and related uses.
Strategy
Modulight’s strategy centers on expanding its laser platform into more indications, geographies, and high-value applications while strengthening commercial execution. It also emphasizes cloud-based services, new business models such as pay-per-treatment, and continued product development to shorten customer time-to-market and deepen switching costs.
A wider platform reduces dependence on a narrow set of clinical uses and increases addressable demand.
A global footprint supports growth and reduces reliance on the Finnish home market.
Cloud and pay-per-treatment models can improve customer lock-in and revenue visibility.
Geography
Modulight is headquartered in Tampere, Finland, and operates through a Finnish parent company with a U.S. subsidiary and other group entities. The company reports that most revenue comes from outside Finland, reflecting a global customer base and exposure to international healthcare and technology markets. Its risk profile is shaped by strong U.S. market focus, while growth efforts also extend to Europe and Asia.
Risks
Modulight faces technology, regulatory, supply-chain, and customer-execution risks typical of specialized medical technology businesses. Its exposure is amplified by reliance on the U.S. market, long product qualification cycles, intellectual property protection, cyber security, and the ability to recruit and retain skilled personnel.
- Technology and competitive riskImpact: HighLikelihood: High
The business depends on keeping its laser platforms and applications relevant in fast-moving niche markets.
Exposure: Medical photonics and high-value applications
- U.S. market and geopolitical exposureImpact: HighLikelihood: High
The company states it focuses especially on the U.S., making it sensitive to tariffs, trade policy, and macro shocks.
Exposure: United States
- Regulatory and product liability riskImpact: HighLikelihood: Medium
Medical devices and clinical applications require approvals and can face claims if products fail or cause harm.
Exposure: Oncology and ophthalmology systems
- Cybersecurity riskImpact: MediumLikelihood: Medium
Greater visibility and connected systems increase the chance of IT disruption or cyber incidents.
Exposure - Key personnel riskImpact: MediumLikelihood: Medium
Specialized engineering and commercial know-how are critical to product development and customer delivery.
Exposure
Accounting
Judgemental itemsThe company notes revenue is recognized mainly by delivery stage, which can shift revenue between periods.
Impact: Affects quarterly comparability and reported growth
Development spending is partly capitalized, so judgment on eligibility affects expenses and intangible assets.
Impact: Influences EBITDA, amortization, and balance sheet assets
Specialized technology assets may need write-downs if programs or demand do not materialize.
Impact: Can materially affect earnings and equity
The company has customer and counterparty exposure, especially with international buyers.
Impact: Affects expected credit losses and working capital
Similar listed companies
Publicly listed companies with a comparable business focus.
Healthier Choices Management Corp.
HCMC · Tobacco Products
Hong Yuan Holding Group
HGYN · Plastic Materials, Synth Resins & Nonvulcan Elastomers
HONG YUAN HOLDING GROUP is a U.S.-listed company in the plastics and synthetic resins value chain.
Valuence Merger Corp. I
VMCAF · Blank Checks
Valuence Merger Corp.
American Exceptionalism Acquisition Corp. A
AEXA · Blank Checks
American Exceptionalism Acquisition Corp.
Artificial Intelligence Technology Solutions Inc.
AITX · Services-Prepackaged Software
Amgen Inc
AMGN · Biological Products, (No Diagnostic Substances)
Last updated: 24/09/2026